ClinicalTrials.gg
CompletedNCT03404284Updated Jan 19, 2018

Assessment of Family Planning and Immunization Service Integration in Malawi

An observational study in Contraception, Contraceptive Usage and Contraception Behavior, sponsored by Jhpiego. Completed. Per ClinicalTrials.gov, last updated 2018-01-19.

Sponsored by Jhpiego · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
43
Sex
All
01

Study summary

This is a mixed methods process evaluation of a programmatic intervention to integrate family planning and immunization services at health facilities and through outreach services in Dowa and Ntchisi districts of Malawi. The study involved qualitative methods (in depth interviews and focus group discussions with service providers, mothers and fathers of infants \<1 year, and supervisors and program managers) as well as secondary analysis of service statistics for family planning and immunization services and of supervision reports.

02

Conditions studied

  • Contraception
  • Contraceptive Usage
  • Contraception Behavior
  • Infant, Newborn, Diseases

Keywords

  • Immunization
03

In context

Contraception Behavior

37 studies on the registry are indexed under Contraception Behavior; 14 are open to participants now.

Browse Contraception Behavior studies →

Lead sponsor

Jhpiego is the lead sponsor of 32 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

43 health facilities and associated outreach sites in Ntchisi and Dowa districts of Malawi

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All health facilities and associated outreach sites in Ntchisi and Dowa districts implementing the integrated approach with support from the USAID-funded Maternal and Child Survival Program

Exclusion criteria

Exclusion Criteria:

  • All health facilities and associated outreach sites not implementing the integrated approach with support from the USAID-funded Maternal and Child Survival Program
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
43 participants (actual)
Patient registry
No

Groups and cohorts

  • Intervention facilities

    Includes 43 health facilities and their associated outreach sites

    Behavioral: Family planning and infant immunization service integration

Interventions

  • BehavioralFamily planning and infant immunization service integration

    The approach involved integration of services through health surveillance assistant (HSA) outreach as well as through the health facility platform. The HSAs provided door to door FP services in their designated communities as well as provided integrated FP and Immunisation services at village clinics and outreach sessions. At outreach sessions, mothers were offered both routine infant immunization and family planning services (pills, condoms, injectables plus referrals for other methods). At health facilities, mothers who sought routine infant immunization services were offered same-day family planning services and those who seek family planning services are also screened for infant immunization schedule completion / need for infant immunization services. HSAs and health facility providers were trained on FP-immunization service integration and were monitored through regular supportive supervision visits.

06

What researchers measure

Primary outcomes

  1. Number of modern family planning users

    Time frame: June 2016 through September 2017 (we also collected pre-intervention data from January to May 2016)

  2. Number of Penta 1 doses administered

    Time frame: June 2016 through September 2017 (we also collected pre-intervention data from January to May 2016)

  3. Number of Penta 3 doses administered

    Time frame: June 2016 through September 2017 (we also collected pre-intervention data from January to May 2016)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03404284
Lead sponsor
Jhpiego
Collaborators
John Snow, Inc.
Responsible party
Sponsor
First posted
Jan 19, 2018
Start date
Jun 2016
Primary completion
Sep 2017
Completion
Sep 2017
Last update
Jan 19, 2018

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion